State Board of Administration of Florida Retirement System’s Relmada Therapeutics RLMD Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio RLMD Stock Details RLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-15,100	Closed	-$34.1K	–	2340
2024 Q1	$34.1K	Buy	+15,100	New	+$72.8K	﹤0.01%	2132
2023 Q2	–	Sell	-15,100	Closed	-$34.1K	–	2490
2023 Q1	$34.1K	Hold	15,100	–	–	﹤0.01%	2232
2022 Q4	$52.7K	Sell	15,100 -7,250	-32%	-$63.7K	﹤0.01%	2276
2022 Q3	$827K	Sell	22,350 -3,260	-13%	-$90.3K	﹤0.01%	1303
2022 Q2	$486K	Buy	+25,610	New	+$559K	﹤0.01%	1665

Other funds holding RLMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Board of Administration of Florida Retirement System's RLMD Position: Q2 2024 in Review

State Board of Administration of Florida Retirement System sold out of Relmada Therapeutics (RLMD) in Q2 2024, closing a stake of 15,100 shares — an estimated $34.1K sold.

State Board of Administration of Florida Retirement System first reported a position in RLMD in Q2 2022 and held it in 5 quarters. The position peaked at $827K in Q3 2022. 79 funds tracked by Wall St. Rank hold RLMD as of Q2 2024.

State Board of Administration of Florida Retirement System reported no remaining Relmada Therapeutics position as of Q2 2024 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 15,100 Relmada Therapeutics shares in Q2 2024, an estimated $34.1K.
State Board of Administration of Florida Retirement System first reported a position in Relmada Therapeutics in Q2 2022 and held it in 5 quarters.
State Board of Administration of Florida Retirement System's Relmada Therapeutics position peaked at $827K in Q3 2022.
79 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2024.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2024, filed 8 Aug 2024.